OPTION AND LICENSE AGREEMENT Between ZYMEWORKS INC. and ATRECA, INC. April 4, 2022Option and License Agreement • August 8th, 2022 • Atreca, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2022 Company Industry JurisdictionThis OPTION AND LICENSE AGREEMENT (the “Agreement”) is effective as of April 4, 2022 (the “Effective Date”), by and between Atreca, Inc., a Delaware corporation, having an address 835 Industrial Road, Suite 400, San Carlos, California 94070 USA (“Atreca”) and Zymeworks Inc., a corporation organized and existing under the laws of British Columbia, having an address at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9 (“Zymeworks”). Zymeworks and Atreca are each referred to individually as a “Party” and together as the “Parties”.